AAAAAA

   
Results: 1-7 |
Results: 7
Sociodemographic and clinical predictors of participation in two randomized trials: Findings from the collaborative ocular melanoma study COMS ReportNo. 7
Authors: Diener-West, M Hawkins, BS Moy, CS Earle, JD
Citation: M. Diener-west et al., Sociodemographic and clinical predictors of participation in two randomized trials: Findings from the collaborative ocular melanoma study COMS ReportNo. 7, CONTR CL TR, 22(5), 2001, pp. 526-537
Cause-specific mortality coding: Methods in the Collaborative Ocular Melanoma Study COMS report no. 14
Authors: Moy, CS Albert, DM Diener-West, M McCaffrey, LD Scully, RE Willson, JKV
Citation: Cs. Moy et al., Cause-specific mortality coding: Methods in the Collaborative Ocular Melanoma Study COMS report no. 14, CONTR CL TR, 22(3), 2001, pp. 248-262
Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma - I. Visual acuity after 3 years - COMS report no. 16
Authors: Melia, BM Abramson, DH Albert, DM Boldt, HC Earle, JD Hanson, WF Montague, P Moy, CS Schachat, AP Simpson, ER Straatsma, BR Vine, AK Weingeist, TA
Citation: Bm. Melia et al., Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma - I. Visual acuity after 3 years - COMS report no. 16, OPHTHALMOL, 108(2), 2001, pp. 348-366
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: Characteristics of patients enrolled and not enrolled
Authors: Diener-West, M Earle, JD Fine, SL Hawkins, BS Moy, CS Reynolds, SM Schachat, AP Straatsma, BR
Citation: M. Diener-west et al., The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: Characteristics of patients enrolled and not enrolled, ARCH OPHTH, 119(7), 2001, pp. 951-965
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings
Authors: Diener-West, M Earle, JD Fine, SL Hawkins, BS Moy, CS Reynolds, SM Schachat, AP Straatsma, BR
Citation: M. Diener-west et al., The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings, ARCH OPHTH, 119(7), 2001, pp. 969-982
Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS)
Authors: Willson, JKV Albert, DM Diener-West, M McCaffrey, L Moy, CS Scully, RE
Citation: Jkv. Willson et al., Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS), ARCH OPHTH, 119(5), 2001, pp. 670-676
Evidence for the role of sunlight exposure in the etiology of choroidal melanoma
Authors: Moy, CS
Citation: Cs. Moy, Evidence for the role of sunlight exposure in the etiology of choroidal melanoma, ARCH OPHTH, 119(3), 2001, pp. 430-431
Risultati: 1-7 |